INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›Immuneering Presents Data At 2026 AACR Conference On Pancreatic Cancer Supporting Atebimetinib's Mechanisms Designed To Extend Survival In Pancreatic Cancer
health

Immuneering Presents Data At 2026 AACR Conference On Pancreatic Cancer Supporting Atebimetinib's Mechanisms Designed To Extend Survival In Pancreatic Cancer

By Info60 UAE Desk•Summary of reporting by Menafn•2d ago•0 views•
(MENAFN - GlobeNewsWire - Nasdaq) - Stable or increased weight was twice as common among pancreatic cancer patients in the atebimetinib + mGnP study, compared to those in a benchmark study - - ...
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Meet Jordic: The Unlikely Voice Of A Heart-Health Warning Men Need To Hear

Menafn

YR Fitness Plans To Expand One-Stop Gym Solutions With Design And Fit-Out Services

Menafn

Dr. Simon Ourian, Whose Patients Have Included Kim Kardashian And Adriana Lima, Launches 'Ask Dr. Ourian'

Menafn

Regentis Biomaterials And The Shift From Symptom Management To Structural Repair In Knee Cartilage Care

Regentis Biomaterials And The Shift From Symptom Management To Structural Repair In Knee Cartilage Care

Menafn

Stucco Restoration At Hillsborough Nursing Center Brings A Beneficial Side Effect

Stucco Restoration At Hillsborough Nursing Center Brings A Beneficial Side Effect

Menafn

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!